Background. Infections with parvovirus B19 (PVB19) can cause significant morbidity in
transplant recipients. Methods. To characterize the epidemiology and clinical spectrum of …

Clinical manifestations of human parvovirus B19 infection can vary widely and may be
atypical in solid organ transplant (SOT) recipients. However, disease is apparent when there …

Up to 9% of renal transplant recipients have severe multifactorial erythropoietin-resistant
anemia. Human parvovirus B19 (PVB19) infection can cause severe anemia and is likely …

Human parvovirus B19 (B19) infection has been known to cause chronic anemia, pure red
cell aplasia (PRCA), glomerulopathy, and allograft dysfunction in kidney transplant (KT) …

Background. Parvovirus B19 (B19) infection is known to cause chronic infection leading to
anemia in immunocompromised patients. Although nosocomial B19 infections in …

We report a 61‐yr‐old kidney transplant recipient with human Parvovirus B19 (HPV B19)
infection presenting as a severe pancytopenia 1 month after transplantation. Bone marrow …

Renal transplant patients were screened for the presence of parvovirus B19, before
transplantation and monthly for 4 months after transplantation, by means of a sensitive …

Parvovirus B19 is a common human pathogen, causing erythema infectiosum in children,
hydrops fetalis in pregnant women, and transient aplastic crisis in patients with chronic …

Background. Chronic red cell aplasia can develop in immunocompromised patients
including transplant recipients infected with parvovirus B19 (PV B19). Renal involvement …

BACKGROUND: Many reports document the transmission of human parvovirus B19 (B19)
infection by clotting factor concentrates manufactured from large plasma pools …